The ISPE Education Committee guides the process of providing webinars to ISPE members and the global community. To keep webinars an active part of ISPE, please consider:
We also appreciate your help in sharing webinar updates with fellow members, whether that is reposting on social media or forwarding a webinar invitation.
Date: December 10, 2026; Time 10 – 11 am EDT
Speakers: Dr. Meghan Cupp Buxton and Dr. Vincent Lo Re
Moderator: Dr. Katsiaryna Bykov
Description
Pharmacoepidemiology and Drug Safety (PDS), the official journal of ISPE, presents the Ronald D. Mann Best Paper Award each year to the strongest contribution within a given volume of the journal. The award winner in 2026 (for contribution in 2025) is research article "Opioid Use After Hip Fracture and Subsequent Fracture Outcomes: A Self-Controlled Case Series Design" by Meghan A. Cupp, Kaleen N. Hayes, Sarah D. Berry, Francesca L. Beaudoin, Melissa R. Riester, Richa Joshi, and Andrew R. Zullo.
In this webinar, the lead author of the paper, Dr. Cupp, will present the study and its findings, from both methodological and clinical perspectives. Dr. Lo Re, PDS Regional Editor for Americas, will describe the process and criteria for selecting the best paper for the award. Audience will have the opportunity to ask questions about the study and the award.
Learning Objectives
Speakers Bios and Emails:
Meghan Cupp Buxton (she/her)
Meg is a postdoctoral research fellow at CAUSALab at the Harvard T.H. Chan School of Public Health. She received her PhD in epidemiology from the Brown University School of Public Health, where she was supported by a predoctoral fellowship from the National Institute on Aging, and her MPH from Imperial College London. Her research focuses on combining information across data sources to address methodological challenges in studies of medication safety and comparative effectiveness.
Buxton, Meghan C. mbuxton@hsph.harvard.edu
Vincent Lo Re, MD, MSCE is Professor of Medicine in the Division of Infectious Diseases of the Robert Wood Johnson Medical School of Rutgers University and Director of the Rutgers Center for Pharmacoepidemiology and Treatment Science within the Rutgers Institute for Health. Dr. Lo Re leads an NIH-funded research program focused on pharmacoepidemiology research. Dr. Lo Re maintains an active clinical practice devoted to the care of patients with chronic viral hepatitis. He has been an active member of the International Society for Pharmacoepidemiology, serving on the Board of Directors from 2015-2018, Scientific Program Chair for the Society’s 35th annual meeting in Philadelphia in August 2019, and President from 2021-2022. He has also been Regional Editor for the Americas of the Society’s journal, Pharmacoepidemiology and Drug Safety, since 2018. He has chaired the US FDA’s Drug Safety and Risk Management Advisory Committee since 2022.
Vincent Lo Re III vincent.lo.re@ifh.rutgers.edu
Moderator:
Katsiaryna Bykov, PharmD, ScD, is a pharmacoepidemiologist and an Assistant Professor of Medicine at the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital and Harvard Medical School. Dr. Bykov has been working with electronic healthcare data to evaluate drug utilization, impact of healthcare interventions, and medication safety and effectiveness for more than a decade. Her current research focuses on the development and application of epidemiologic methods, including self-controlled designs, for evaluating the safety and effectiveness of treatment combinations and drug-drug interactions. Dr. Bykov has been an Associate Editor of Pharmacoepidemiology and Drug Safety since 2022 and served as the Chair of ISPE Education Committee during the 2025-2026 period.
Katsiaryna Bykov kbykov@bwh.harvard.edu
